Brokerages Set Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) PT at $49.94
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twenty brokerages that are currently covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and two have assigned a strong […]
More Stories
Denka Company Limited (OTCMKTS:DENKF) Short Interest Update
Denka Company Limited (OTCMKTS:DENKF – Get Free Report) was the recipient of a significant growth in short interest in December....
Nexus Industrial REIT (OTCMKTS:EFRTF) Short Interest Up 6.7% in December
Nexus Industrial REIT (OTCMKTS:EFRTF – Get Free Report) was the target of a large growth in short interest during the...
Persimmon (OTCMKTS:PSMMY) Sets New 52-Week Low – Should You Sell?
Persimmon Plc (OTCMKTS:PSMMY – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The stock...
Hemostemix (CVE:HEM) Trading Up 71.4% – What’s Next?
Hemostemix Inc. (CVE:HEM – Get Free Report) shares shot up 71.4% on Wednesday . The stock traded as high as...
Rugby Resources (CVE:RUG) Stock Price Down 25% – Time to Sell?
Rugby Resources Ltd. (CVE:RUG – Get Free Report) shares traded down 25% during mid-day trading on Monday . The company...
Canfor Pulp Products (TSE:CFX) Reaches New 52-Week Low – Time to Sell?
Canfor Pulp Products Inc. (TSE:CFX – Get Free Report) shares reached a new 52-week low during trading on Monday ....